Professor Philip Rosenstiel, W3 Professor of Clinical Molecular Biology, Director, Institute of Clinical Molecular Biology (IKMB), Kiel University
- 👤 Speaker: Prof Philip Rosenstiel, W3 Professor of Clinical Molecular Biology, Director, Institute of Clinical Molecular Biology (IKMB), Kiel University
- 📅 Date & Time: Thursday 14 May 2026, 16:00 - 17:00
- 📍 Venue: Max Perutz Lecture Theatre, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH
Abstract
This Cambridge Immunology Network Seminar will take place on Thursday 14th May 2026, starting at 4:00pm, in the Ground Floor Lecture Theatre, Jeffrey Cheah Biomedical Centre (JCBC)
Speaker: Prof Philip Rosenstiel, W3 Professor of Clinical Molecular Biology, Director, Institute of Clinical Molecular Biology (IKMB), Kiel University (CAU) / UKSH , Germany
Short Bio: Philip Rosenstiel is the recipient of a Schleswig-Holstein Excellence Chair in Clinical Molecular Biology and Head of the Systems Immunology Group at the Institute of Clinical Molecular Biology, Kiel University since 2016. His research is focused on the interaction of the intestinal mucosa with the resident microbiome as an explanatory model of how the environment shapes disease susceptibility. His team is specialized in chronic inflammation and investigates cellular and murine inflammation models as well as large scale patient cohorts using state-of-the-art genomic techniques. He heads the Competence Centre for Genomic Analysis, which represents one of four German National NGS Sequencing Hubs of the DFG . To date, he has published >450 articles in peer-reviewed journals (H-index: 118 (Google scholar); citations: >90,000). Among other involvements, Philip is coordinator of the Horizon Europe research network PerPrev-CID, co-coordinates the IMI2 proposal ImmUniverse and is member of the steering board of the DFG Excellence Cluster Precision Medicine in Chronic Inflammation. He has acquired >40 million EUR of grant support. He has been elected as vice dean for research at the medical faculty of Kiel University and as head of the governing board for clinical translational research of Kiel and Lübeck University (Precision Health in Schleswig-Holstein, PHSH ). He acts as ad-hoc reviewer for journals (incl. NEJM , Nature, Science, Cell, Immunity, Cell Metabolism, Nature Immunology) and grant committees (DFG, INSERM , MRC, EU)
Title: To be confirmed
Host: Prof Arthur Kaser, Professor of Gastroenterology, Cambridge University
Refreshments will be available following the seminar.
Series This talk is part of the Cambridge Immunology Network Seminar Series series.
Included in Lists
- All Talks (aka the CURE list)
- Cambridge Immunology
- Cambridge Immunology Network Seminar Series
- Cambridge Infectious Disease
- Cambridge Infectious Diseases
- Liam
- LMB
- Max Perutz Lecture Theatre, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)

Prof Philip Rosenstiel, W3 Professor of Clinical Molecular Biology, Director, Institute of Clinical Molecular Biology (IKMB), Kiel University
Thursday 14 May 2026, 16:00-17:00